Hindenburg research's claims baseless, misleading: REITs Association

Hindenburg research's claims baseless, misleading: REITs Association


The Adani Group termed the latest allegations malicious and based on manipulation of select public information.


Indian REITs Association on Monday said that claims made by the US-based short seller Hindenburg Research suggesting that the REIT framework made by markets regulator Sebi serves the interests of a select few are “baseless and misleading”.


In fact, the association has commended Sebi and its leadership for crafting a “rigorous regulatory environment” that includes comprehensive periodic reporting requirements, mandatory independent valuations, and strict governance standards.


These measures are designed to enhance transparency and protect investor interests, it added.


The statement came after the Hindenburg report on Saturday alleged that recent amendments to Sebi’s REIT Regulations 2014 were made to benefit a specific multinational financial conglomerate. In this regard, the markets regulator stated that Sebi (REIT) Regulations, 2014 has been amended from time to time.


In a statement, the association said that since the introduction of REIT (Real Estate Investment Trust) regulations in 2014, India has established a strong and transparent regulatory framework that aligns with global best practices.


“Developed in consultation with all market participants, this framework ensures the highest levels of investor protection for both –domestic and international institutional investors, as well as retail investors,” it said.


Hindenburg Research on Saturday launched a broadside against market regulator Sebi chairperson Madhabi Puri Buch, alleging she and her husband had stakes in obscure offshore funds used in the alleged Adani money siphoning scandal.


Sebi chairperson Buch and her husband Dhaval denied the allegations as baseless and asserted their finances are an open book. Her husband Dhaval Buch is a senior advisor with Blackstone.


The Adani Group termed the latest allegations malicious and based on manipulation of select public information.


The company said it has no commercial relationship with the Sebi chairperson or her husband.


Indian REITs Association, which counts Brookfield India Real Estate Trust, Embassy Office Parks REIT, Mindspace Business Parks REIT, and Nexus Select Trust — as their founding members, said that the sector’s growth has drawn significant interest and participation from prominent global institutional investors.


These investors’ participation not only strengthens the trust and credibility of India’s financial system but also provides investors with a dependable and transparent avenue to engage in the country’s expanding real estate market.


Currently, there are four listed REITs on the Indian stock exchanges, collectively managing assets worth over Rs 1.4 lakh crore and serving over 2.4 lakh crore unitholders. These REITs have distributed over Rs 18,000 crore, with the market capitalisation of the asset class reaching about Rs 80,000 crore.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

First Published: Aug 12 2024 | 5:05 PM IST



Source link

Balrampur Chini Q1 PAT slips 5% YoY to Rs 70 cr

Balrampur Chini Q1 PAT slips 5% YoY to Rs 70 cr


On consolidated basis, Balrampur Chini Mills’ net profit declined 4.57% to Rs 70.15 crore in Q1 FY25 as against Rs 73.51 crore reported in Q1 FY24.

Revenue from operations grew by 2.3% to Rs 1,421.60 crore in Q1 FY25 as compared with Rs 1,389.62 crore recorded in the same period a year ago.

Profit before tax for the quarter was at Rs 102.38 crore, down 4.06% from Rs 106.71 crore posted in Q1 FY24.

The companys revenue from Sugar business stood at Rs 1,131.61 crore (up 1.39% YoY) while income from Distillery came in at Rs 424.07 crore (down 8.99% YoY) during the period under review.

On the margins front, the firms operating margin reduced to 11.69% in Q1 FY25 as compared with 11.74% recorded in Q1 FY24. Net profit margin declined to 4.93% in Q1 FY25 from 5.29% registered in corresponding quarter last fiscal.

Balrampur Chini Mills is one of the largest integrated sugar companies in India. The allied businesses of the Company comprise distillery operations and cogeneration of power.

Shares of Balrampur Chini Mills added 0.96% to Rs 495.55 on the BSE.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Aug 12 2024 | 3:58 PM IST



Source link

Balrampur Chini Q1 PAT slips 5% YoY to Rs 70 cr

Next Mediaworks Ltd leads losers in 'B' group


Adroit Infotech Ltd Partly Paidup, Rajdarshan Industries Ltd, Ambika Cotton Mills Ltd and 3P Land Holdings Ltd are among the other losers in the BSE’s ‘B’ group today, 12 August 2024.

Adroit Infotech Ltd Partly Paidup, Rajdarshan Industries Ltd, Ambika Cotton Mills Ltd and 3P Land Holdings Ltd are among the other losers in the BSE’s ‘B’ group today, 12 August 2024.

Next Mediaworks Ltd lost 13.83% to Rs 8.1 at 14:30 IST.The stock was the biggest loser in the BSE’s ‘B’ group.On the BSE, 45680 shares were traded on the counter so far as against the average daily volumes of 13158 shares in the past one month.

Adroit Infotech Ltd Partly Paidup crashed 12.05% to Rs 5.18. The stock was the second biggest loser in ‘B’ group.On the BSE, 1.3 lakh shares were traded on the counter so far as against the average daily volumes of 19146 shares in the past one month.

Rajdarshan Industries Ltd tumbled 9.99% to Rs 64.12. The stock was the third biggest loser in ‘B’ group.On the BSE, 5291 shares were traded on the counter so far as against the average daily volumes of 13612 shares in the past one month.

Ambika Cotton Mills Ltd corrected 9.86% to Rs 1770. The stock was the fourth biggest loser in ‘B’ group.On the BSE, 16034 shares were traded on the counter so far as against the average daily volumes of 6911 shares in the past one month.

3P Land Holdings Ltd shed 9.32% to Rs 46.29. The stock was the fifth biggest loser in ‘B’ group.On the BSE, 17111 shares were traded on the counter so far as against the average daily volumes of 21984 shares in the past one month.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Aug 12 2024 | 2:45 PM IST



Source link

Morepen Labs stock soars 6% on strong Q1 show; medical device biz grows 20%

Morepen Labs stock soars 6% on strong Q1 show; medical device biz grows 20%


An oximeter is pictured above


Shares of Morepen Laboratories soared 6.46 per cent at Rs 61.89 per share on the BSE in Monday’s intraday trade. The stock price surged after the company reported its April-June quarter of financial year 2024-25 (Q1FY25) on August 12, 2024. 


For the first quarter of FY25, the company reported net revenue of Rs 458.64 crore, marking a 14 per cent increase, year-on-year (Y-o-Y) from Rs 403.46 crore in Q1FY24. 


The company’s expenditure for the same period rose by 8 per cent to Rs 403.59 crore from Rs 374.95 crore a year earlier. 


Earnings before interest, tax, depreciation and amortisation (Ebitda) rose by 93 per cent, reaching Rs 55.05 crore compared to Rs 28.51 crore in Q1FY24. 


The company reported its cash surplus at Rs 53.89 crore from Rs 28.23 crore, up 91 per cent Y-o-Y in Q1 of FY25. 


The company’s profit after tax (PAT) increased by 147 per cent, reaching Rs 36.17 crore, compared to Rs 14.63 crore in Q1FY24. The quarterly earnings per share (EPS) improved by 147 per cent to Rs 0.71 in the quarter under review from Rs 0.29 in the same quarter last year. 


In Q1FY25, the medical devices business recorded revenue of Rs 138 crore, marking a 20 per cent growth Y-o-Y. The pharma segment on the other hand, reported revenue of Rs 320 crore, reflecting an 11 per cent year-on-year growth. This segment accounted for 70 per cent of the company’s consolidated quarterly revenues, the company said in a statement. 


Morepen Laboratories also informed that it successfully completed a Rs 200 crore qualified institutional placement (QIP), which was oversubscribed by 1.68 times. Key investors included Bank of America, Samsung India, Citigroup, Societe Generale, Nomura, BNP Paribas, Morgan Stanley, and Eminence, signalling strong confidence in Morepen’s future, the company said in an exchange filing. 


“This strategic fundraise marks a pivotal point in the company’s growth journey. With the influx of this new capital, we will accelerate our capacity expansion plans and broaden our market reach. With this fresh infusion of capital, the company can clearly focus on its two growth engines – Medical Devices & Pharma – and reposition itself for growth in select categories with an end to-end supply chain from manufacturing to marketing,” said Sushil Suri, Chairman and Managing Director of Morepen Laboratories. 


He further said that the company will have an increased focus on research and backward integration, fostering innovation and cost reduction, thereby positioning the company as a reliable partner for global outsourcing in both the Medical Devices and Pharma sectors for export markets. 


Morepen Labs is presently trading at a price to earnings multiple of 28.71 times, while trading at an earning per share (EPS) of Rs 2.02.


At 01:25 PM; the stock price of the company was trading 2.53 per cent higher at Rs 59.60 per share on the BSE. By comparison the BSE Sensex surged by 0.22 per cent at 79,877 levels.

First Published: Aug 12 2024 | 1:35 PM IST



Source link

360 One WAM: Trading strategies in IIFL group stocks post Hindenburg claims

360 One WAM: Trading strategies in IIFL group stocks post Hindenburg claims


Shares of IIFL Group of companies were in focus in trades on Monday, August 12, after Hindenburg Research in its report named one of IIFL’s group company namely – 360 One WAM, in its scathing attack on Sebi chairperson Madhabi Puri Buch.


As per the Hindenburg report, Madhabi Buch and her husband Dhaval Buch, first appear to have opened their account with IPE Plus Fund 1 on June 5, 2015 in Singapore, per whistleblower documents. A declaration of funds, signed by a principal at IIFL states that the source of the investment as ‘salary’ and the couple’s net worth estimated at $10 million.


360 One WAM, an asset and wealth management firm formerly known as IIFL Wealth Management, has played down the allegations made by Hindenburg Research against the Sebi chief.

“The fund was managed as a discretionary fund by the investment manager. No investor had any involvement in the fund’s operations or investment decisions. Madhabi Buch and Dhaval Buch’s holdings in the fund were less than 1.5 per cent of the total inflow into the fund,” disclosed 360 One in its statement.


“At its peak, the fund’s assets under management (AUM) reached approximately $48 million, with over 90 per cent of the fund consistently invested in bonds,” said the wealth management firm.


Meanwhile on the bourses today, shares of 360 One WAM, IIFL Securities and IIFL Finance declined up to 5 per cent in intra-day deals; but soon recouped most of the day’s losses.


Here’s how these stocks are placed on the charts:


360 One WAM


Current Price: Rs 1,037


Bias: Range-bound likely


Support: Rs 1,025; Rs 930


Resistance: Rs 1,115; Rs 1,150


The stock price of 360 One WAM is seen treading along its 20-DMA (Daily Moving Average) for the last six trading sessions. The 20-DMA stands at Rs 1,025, with next key support level placed at Rs 930 – its 50-DMA. On the weekly scale, the stock is seen facing resistance around the 200-WMA (Weekly Moving Average) at Rs 1,150, with interim resistance seen at Rs 1,115.

Thus, implying that the stock may consolidate in the broad range of Rs 930 – Rs 1,150, before making its next decisive move. CLICK HERE FOR THE CHART


IIFL Finance 


Current Price: Rs 416


Upside Potential: 23.8%


Support: Rs 411; Rs 385


Resistance: Rs 450 and Rs 465


IIFL Finance has been trading with a negative bias post the steep fall in March 2024 due to RBI’s ban on fresh gold loan disbursals by the NBFC. 


The stock, however, had recovered partly from a low of RS 316 and went on test its 200-DMA at Rs 535 levels in early July. The stock, however, is seen drifting lower. The stock has near support at Rs 411 and Rs 385 – wherein stands the 200-wMA.

As long as these support zones holds, the stock can attempt to pullback to higher levels once again. On the upside, the stock may attempt a re-test of its 200-DMA at Rs 515 levels, with interim resistance seen around its 20-DMA at Rs 450 and the 50-DMA at Rs 465. CLICK HERE FOR THE CHART


IIFL Securities


Current Price: Rs 209


Upside Potential: 29.7%


Support: Rs 184; Rs 165


Resistance: Rs 240 and Rs 255


IIFL Securities is seen trading with a bullish bias on the weekly scale; The stock is not only trading firmly above its key moving averages, but has also been making higher highs and higher lows since the breakout above it 100-WMA in August 2023.

As per the current chart pattern, the stock seems to be in the process of seeking support around the 20-WMA, which stands at Rs 184; below which the stock is expected to find considerable support around Rs 165 levels. On the upside, the stock can potentially rally to Rs 270 levels; with interim resistance seen at Rs 240 and Rs 255 levels. CLICK HERE FOR THE CHART

 

First Published: Aug 12 2024 | 12:54 PM IST



Source link

Balrampur Chini Q1 PAT slips 5% YoY to Rs 70 cr

Transgene Biotek reports consolidated net profit of Rs 0.20 crore in the June 2024 quarter


Sales decline 50.00% to Rs 0.05 crore

Net profit of Transgene Biotek reported to Rs 0.20 crore in the quarter ended June 2024 as against net loss of Rs 0.13 crore during the previous quarter ended June 2023. Sales declined 50.00% to Rs 0.05 crore in the quarter ended June 2024 as against Rs 0.10 crore during the previous quarter ended June 2023.

ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales0.050.10 -50 OPM %-820.00-120.00 PBDT0.22-0.11 LP PBT0.20-0.13 LP NP0.20-0.13 LP

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Aug 12 2024 | 11:58 AM IST



Source link

YouTube
Instagram
WhatsApp